Hu-Lieskovan, Siwen <br/><br/>
Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non-Small Cell Lung Cancer.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  08 2019 
 - 5061-5068 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-18-4275  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Antineoplastic Agents, Immunological--administration & dosage<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Molecular Targeted Therapy<br/>Neoplasm Grading<br/>Neoplasm Metastasis<br/>Neoplasm Staging<br/>Treatment Outcome<br/>Exome Sequencing